[NEW GUN] Weaponry [BETA] vs Hospital Tycoon
[NEW GUN] Weaponry [BETA] currently leads with 590 concurrent players against 188, a 3.1Γ advantage. On all-time peak the record belongs to [NEW GUN] Weaponry [BETA] at 834 concurrent players, versus 501. Lifetime, Hospital Tycoon has more visits (377.7M vs 232.5M). Full side-by-side history for [NEW GUN] Weaponry [BETA] and Hospital Tycoon is charted above.
[π₯NEW GUN] Weaponry [BETA]
590
playing now
834 24h peak Β· 232.5M visits
VS
Hospital Tycoon π·
188
playing now
260 24h peak Β· 377.7M visits
Player count history
[NEW GUN] Weaponry [BETA]Hospital Tycoon
Head to head
| Metric | [NEW GUN] Weaponry [BETA] | Hospital Tycoon | Difference |
|---|---|---|---|
| Playing now | 590 | 188 | 402 (3.1Γ) |
| 24h peak | 834 | 260 | 574 (3.2Γ) |
| 24h average | 631 | 175 | 456 (3.6Γ) |
| 7-day peak | 834 | 467 | 367 (1.8Γ) |
| 7-day average | 604 | 207 | 397 (2.9Γ) |
| 30-day peak | 834 | 467 | 367 (1.8Γ) |
| All-time peak | 834 | 501 | 333 (1.7Γ) |
| 24h change | β² 9.0% | βΌ 15.5% | β |
| 7d change | β | β | β |
| Total visits | 232.5M | 377.7M | 145.3M (1.6Γ) |
| Visits (24h) | 122.9K | 18.7K | 104.3K (6.6Γ) |
| Visits (7d) | 252.5K | 105.4K | 147.1K (2.4Γ) |
| Favorites | 502K | 3.4M | 2.9M (6.7Γ) |
| Rating | 77.4% | 93.3% | β |
| Global rank (players) | #1,780 | #2,632 | of 4,743 |
| Trending score | 12.1 | -31.3 | β |
| Created | Jun 12, 2019 | Jul 5, 2021 | β |
| Genre | Shooter | Simulation | β |
Other comparisons
[NEW GUN] Weaponry [BETA] vs Easy Size Obby[NEW GUN] Weaponry [BETA] vs [] DONATE MODDED X[NEW GUN] Weaponry [BETA] vs [UPD] Rescue Pets! [Pet Companion][NEW GUN] Weaponry [BETA] vs College Football[NEW GUN] Weaponry [BETA] vs Soccer Manager Tycoon[NEW GUN] Weaponry [BETA] vs [] Unboxing SimulatorCompare two other games β
Both games are sampled on the same schedule and plotted on a shared time axis, so the comparison is like for like. Peaks, averages and growth come from RoVitals's own recorded history β 3 days for [NEW GUN] Weaponry [BETA], 5 for Hospital Tycoon.